Vaccines and Immunotherapy — Predicted 2026

AI-Predicted Question Angles for UPSC 2026

Based on trend analysis, current affairs, and recurring themes in Vaccines and Immunotherapy.

India's Indigenous mRNA Vaccine Development and its Strategic Implications

High

The successful development and potential widespread deployment of India's first indigenous mRNA vaccine (e.g., GEMCOVAC-19) would be a major milestone. UPSC is likely to test its scientific basis, the challenges overcome, and its strategic importance for India's self-reliance ('Atmanirbhar Bharat'), future pandemic preparedness, and vaccine diplomacy. This combines science, technology, economy, and international relations.

Ethical and Access Challenges of Advanced Immunotherapies (e.g., CAR-T) in India

Medium to High

With the CDSCO approval of India's first indigenous CAR-T cell therapy, the topic of advanced, high-cost therapies becomes highly relevant. Questions could focus on the ethical dilemmas of prioritizing access, the economic burden on patients/healthcare systems, the role of government in subsidies, and the regulatory framework for such complex treatments. This links to social justice, public health policy, and bioethics [VY:SCI-07-03].

Convergence of AI/Machine Learning with Vaccine and Immunotherapy Development

Medium

The role of Artificial Intelligence and Machine Learning in accelerating drug discovery, identifying novel vaccine candidates, predicting immune responses, and personalizing immunotherapy regimens is a rapidly evolving field. UPSC often tests emerging technologies and their applications. A question could explore how AI is transforming medical biotechnology, particularly in these areas, and its potential impact on future healthcare.

Global Health Security and India's Role in Vaccine Supply Chains

Medium

The COVID-19 pandemic exposed vulnerabilities in global health security and supply chains. India's position as a major vaccine manufacturer and its 'Vaccine Maitri' initiative highlight its critical role. Questions could explore how India can further strengthen global health security, diversify vaccine production, and ensure equitable access, especially in the face of future pandemics or biothreats.